Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit

被引：0
|
作者：
Jan Johnson
Wendy Somerfield
Simon R. Johnson
机构：
[1] University of Nottingham,Centre for Respiratory Research, Translational Medical Sciences and Biodiscovery Institute, School of Medicine
[2] Nottingham University Hospitals NHS Trust,National Centre for Lymphangioleiomyomatosis
[3] Nottingham NIHR Biomedical Research Centre,undefined
来源：
Orphanet Journal of Rare Diseases | / 19卷
关键词：
Tuberous sclerosis complex; Lymphangioleiomyomatosis; Screening; mTOR inhibitor; Pneumothorax; Angiomyolipoma; Epilepsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis
    Yoshida, Soichiro
    Hayashi, Tetsuo
    Ishii, Nobuyuki
    Yoshinaga, Atsushi
    Ohno, Rena
    Terao, Toshiya
    Watanabe, Toru
    Yamada, Takumi
    Osada, Hisato
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (3-4) : 413 - 415
  • [32] Association of oestrogen-containing contraceptives with pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex - Findings from a survey
    Sauter, Matthias
    Sigl, Jannina
    Schotten, Klaus-Juergen
    Guenthner-Biller, Margit
    Knabl, Julia
    Fischereder, Michael
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2014, 19 (01) : 39 - 44
  • [33] Tuberous sclerosis complex-lymphangioleiomyomatosis involving several visceral organs: A case report
    Chen, Hong-Bin
    Xu, Xiao-Hong
    Yu, Cai-Gui
    Wan, Meng-Ting
    Feng, Chuang-Li
    Zhao, Zhi-Yu
    Mei, Dan-E
    Chen, Jin-Ling
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (24) : 7085 - 7091
  • [34] Giant angiomyolipoma associated with marked pulmonary lesions suggesting lymphangioleiomyomatosis in a patient with tuberous sclerosis
    Tüzel E.
    Kirkali Z.
    Mungan U.
    Cüler C.
    Sade M.
    International Urology and Nephrology, 2000, 32 (2) : 219 - 222
  • [35] A Comparison of Clinical and Radiological Presentations of Sporadic and Tuberous Sclerosis Complex-Associated Lymphangioleiomyomatosis
    Savage, Taylor E.
    Geenen, Kennedy R.
    Price, Melissa C.
    El-Chemaly, Souheil Y.
    Henske, Elizabeth P.
    Sharma, Amita
    Thiele, Elizabeth A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2025, 197 (01)
  • [36] Hyponatremia: A Tip of the Iceberg in the Late Diagnosis of Tuberous Sclerosis Associated With Lymphangioleiomyomatosis
    Paiva, David
    De Carvalho, Anabela
    Campos, Ana Luisa
    Goncalves, Filipa
    Silva, Cristina
    Miranda, Olinda
    Barbosa, Sandra
    Cotter, Jorge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [37] Efficacy and Safety of Sirolimus for Renal Angiomyolipoma in Patients with Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis: A Systematic Review
    Peng, Zhu-feng
    Yang, Lu
    Wang, Ting-ting
    Han, Ping
    Liu, Zhen-hua
    Wei, Qiang
    JOURNAL OF UROLOGY, 2014, 192 (05) : 1424 - 1430
  • [38] Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial
    Bissler, John J.
    Kingswood, John Christopher
    Radzikowska, Elzbieta
    Zonnenberg, Bernard A.
    Frost, Michael
    Belousova, Elena
    Sauter, Matthias
    Nonomura, Norio
    Brakemeier, Susanne
    de Vries, Petrus J.
    Berkowitz, Noah
    Miao, Sara
    Segal, Scott
    Peyrard, Severine
    Budde, Klemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (01) : 111 - 119
  • [39] A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex
    Krymskaya, Vera P.
    Courtwright, Andrew M.
    Fleck, Victoria
    Dorgan, Daniel
    Kotloff, Robert
    McCormack, Francis X.
    Kreider, Maryl
    RESPIRATORY MEDICINE, 2020, 163
  • [40] Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
    Franz, David Neal
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1181 - 1192
12345